Description
This product utilizes NK cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO31). We employs the pUC (T7-RFP-β-catenin-NotI) vector components and the SynExpress system of the introns Substitution/Adaptive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO31
Species Reactivity
Human
Cell Source
NK cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
β-catenin
Insertion Sites
NotI
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
pUC
Transformation Accuracy
0.92
Cell Culture
Plate Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.